-
Product Insights
NewObsessive-Compulsive Disorder Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Obsessive-Compulsive Disorder Clinical Trials Market Report Overview The Obsessive-Compulsive Disorder clinical trial market research report provides an overview of the Obsessive-Compulsive Disorder clinical trials scenario. The report provides top-line data relating to the clinical trials on Obsessive-Compulsive Disorder. It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type....
-
Product Insights
Attention Deficit Hyperactivity Disorder (ADHD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
ADHD Clinical Trials Market Report Overview The ADHD clinical trial market research report provides an overview of ADHD clinical trials scenario. The report provides top-line data relating to the clinical trials on ADHD. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
-
Sector Analysis
Schizophrenia Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
The schizophrenia market size was $9.0 billion in 2021 and is expected to achieve a CAGR of more than 3% during 2021-2031. Schizophrenia is characterized by several symptom domains including positive symptoms (such as hallucinations, delusions, and disorganized speech), negative symptoms (such as a flat affect and poverty of speech), and cognitive deficits (including impaired attention, memory, and executive functions). The schizophrenia market research report provides an overview of the risk factors, comorbidities, and global and historical trends for schizophrenia...
-
Sector Analysis
Schizophrenia Epidemiology Analysis and Forecast, 2021-2031
In the 7MM, the total prevalent cases of schizophrenia were 5,121,015 in 2021. The cases are expected to grow at an AGR of less than 1% during the period 2021-2031. Schizophrenia is a chronic and debilitating mental illness, characterized by delusions, hallucinations, disorganized speech, trouble with thinking, and a lack of motivation. Schizophrenia is among the most disabling and economically catastrophic medical disorders, ranked by the World Health Organization (WHO) as one of the top 10 illnesses contributing to the...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.